Current Neuro-Oncology
Volume
25 Number 2
31 January 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 2, 31 January
Kim N, Lim
DH, Choi JW, Lee JI, Kong DS, Seol HJ, Nam DH.
Clinical
Outcomes of Moderately Hypofractionated Concurrent
Chemoradiotherapy for Newly Diagnosed Glioblastoma.
Yonsei
Med J. 2023 Jan 16, 2023;64(2):94-103∟.
doi: 10.3349/ymj.2022.0352∟.
PMID: 36719016∟.
Observational study. ˍ
Nishikawa R, Yamasaki F, Arakawa Y,
Muragaki Y, Narita Y, Tanaka S, Yamaguchi S, Mukasa A, Kanamori
M.
Safety
and efficacy of tumour-treating fields (TTFields) therapy for
newly diagnosed glioblastoma in Japanese patients using the
Novo-TTF System: a prospective post-approval study.
Jpn
J Clin Oncol. 2023 Jan 16:hyad001∟.
doi: 10.1093/jjco/hyad001∟.
PMID: 36647599∟.
Interventional study. ˍ
Maraqah HH, Abu-Asab MS, Lee HS,
Aboud O.
Astrocytoma
and IDH1-Wildtype Glioblastoma (GBM) Cells Colonize Tumor Vessels
and Deploy Vascular Mimicry.
Res
Sq [Preprint]. 2023 Jan 17:rs.3.rs-2456733∟.
doi: 10.21203/rs.3.rs-2456733/v1∟.
PMID: 36712042∟.
Laboratory investigation. ˍ
Mizuhata M, Takamatsu S, Shibata S,
Sakurai T, Minamikawa R, Yamazaki M, Kinoshita M, Miyashita K,
Kumano T, Nakada M, Gabata T.
Patterns
of failure in glioblastoma multiforme following Standard (60 Gy)
or Short course (40 Gy) radiation and concurrent temozolomide.
Jpn
J Radiol. 2023 Jan 17∟.
doi: 10.1007/s11604-023-01386-2∟.
PMID: 36648706∟.
Observational study˰ ˍ
Orzan F, De Bacco F, Lazzarini E,
Crisafulli G, Gasparini A, Dipasquale A, Barault L, Macagno M,
Persico P, Pessina F, Bono B, Giordano L, Zeppa P, Melcarne A,
Cassoni P, Garbossa D, Santoro A, Comoglio PM, Indraccolo S,
Simonelli M, Boccaccio C.
Liquid
biopsy of cerebrospinal fluid enables selective profiling of
glioma molecular subtypes at first clinical presentation.
Clin
Cancer Res. 2023 Jan 17:CCR-22-2903∟.
doi: 10.1158/1078-0432.CCR-22-2903∟.
PMID: 36648487∟.
Observational study. ˍ
Shimizu S,
Nakai K, Li Y, Mizumoto M, Kumada H, Ishikawa E, Yamamoto T,
Matsumura A, Sakurai H.
Boron
Neutron Capture Therapy for Recurrent Glioblastoma Multiforme:
Imaging Evaluation of a Case With Long-Term Local Control and
Survival.
Cureus.
2023 Jan 17;15(1):e33898∟.
doi: 10.7759/cureus.33898∟.
PMID: 36819302∟.
Case report. ˍ
Woo PYM, Law
THP, Lee KKY, Chow JSW, Li LF, Lau SSN, Chan TKT, Ho JMK, Lee MWY,
Chan DTM, Poon WS.
Repeat
resection for recurrent glioblastoma in the temozolomide era: a
real-world multi-centre study.
Br
J Neurosurg. 2023 Jan 18:1-9∟.
doi: 10.1080/02688697.2023.2167931∟.
PMID: 36654527∟.
Observational study˰ ˍ
*
Chattrairat K, Yasui T, Suzuki S, Natsume A, Nagashima K, Iida M,
Zhang M, Shimada T, Kato A, Aoki K, Ohka F, Yamazaki S, Yanagida
T, Baba Y.
All-in-One Nanowire Assay
System for Capture and Analysis of Extracellular Vesicles from an
ex Vivo
Brain Tumor Model.
ACS Nano. 2023 Jan 19,
2023;17(3):2235-2244∟.
doi: 10.1021/acsnano.2c08526∟.
PMID: 36655866∟.
Laboratory investigation. ˍ
ˍ
Fu JB, Gupta
E, Morishita S, Andersen CR, Ngo-Huang AT, Engle JP, Guo
Y.
Frequency
and reasons for unplanned transfer to the primary acute care
service of inpatient rehabilitation glioblastoma multiforme
patients.
Support
Care Cancer. 2023 Jan 19;31(2):122∟.
doi: 10.1007/s00520-023-07591-z∟.
PMID: 36653554∟.
Observational study˰ ˍ
Li L, Qin K, Pan Y, Mao C, Alafate
W, Tan P, Zhang N, Tang K.
The
efficacy and safety of intraoperative radiotherapy in the
treatment of recurrent high-grade glioma: a single-center
prospective study.
World
Neurosurg. 2023 Jan 19:S1878-8750(23)00066-9∟.
doi: 10.1016/j.wneu.2023.01.050∟.
PMID: 36682529∟.
Observational study˰ ˍ
Vymazal J,
Kazda T, Novak T, Slanina P, Sroubek J, Klener J, Hrbac T, Syrucek
M, Rulseh AM.
Eighteen
years' experience with tumor treating fields in the treatment of
newly diagnosed glioblastoma.
Front
Oncol. 2023 Jan 19;12:1014455∟.
doi: 10.3389/fonc.2022.1014455∟.
PMID: 36741707∟.
Observational study, Review. ˍ
Chen Z, Guo Z, Wang J, Cao D, Xu Y,
Dong F, Wan F.
Clinical
features and outcomes of pediatric intracranial gliomas: results
from single center's 226 cases and corroborated with SEER
database.
Childs
Nerv Syst. 2023 Jan 20∟.
doi: 10.1007/s00381-023-05841-3∟.
PMID: 36662273∟.
Observational study˰ ˍ
Muragaki Y,
Ishikawa E, Maruyama T, Nitta M, Saito T, Ikuta S, Komori T,
Kawamata T, Yamamoto T, Tsuboi K, Matsumura A, Nakamura H, Kuroda
J, Abe T, Momii Y, Saito R, Tominaga T, Tabei Y, Suzuki I, Arakawa
Y, Miyamoto S, Matsutani M, Karasawa K, Nakazato Y, Maebayashi K,
Hashimoto K, Ohno T.
A
multicenter, randomized, placebo-controlled phase IIb trial of an
autologous formalin-fixed tumor vaccine for newly diagnosed
glioblastomas.
J
Neurosurg. 2023 Jan 20:1-11∟.
doi: 10.3171/2022.12.JNS221221∟.
PMID: 36670529∟.
Interventional study˰ ˍ
Jing L, Qian
Z, Gao Q, Sun R, Zhen Z, Wang G, Yang X, Li H, Guo T, Zhang
W.
Diffuse
midline glioma treated with epigenetic agent-based
immunotherapy.
Signal
Transduct Target Ther. 2023 Jan 20;8(1):23∟.
doi: 10.1038/s41392-022-01274-7∟.
PMID: 36658142∟.
Case report. ˍ
*
Ravin R, Cai TX, Li A, Briceno N, Pursley RH, Garmendia-Cedillos
M, Pohida T, Wang H, Zhuang Z, Cui J, Morgan NY, Williamson NH,
Gilbert MR, Basser PJ.
"Tumor
Treating Fields" delivered via electromagnetic induction have
varied effects across glioma cell lines and electric field
amplitudes.
bioRxiv [Preprint]. 2023 Jan
20:2023.01.18.524504∟.
doi: 10.1101/2023.01.18.524504∟.
PMID: 36789415∟.
Laboratory investigation. ˍ
Amelot A, Terrier LM, Mathon B,
Joubert C, Picart T, Jecko V, Bauchet L, Benard F, Castel X,
Chenin L, Cook AR, Emery E, Figarella-Branger D, Gauchotte G,
Graillon T, Jouvet A, Kalamarides M, Knafo S, Lazard A, Lubrano V,
Mokhtari K, Rigau V, Roualdes V, Rousseau A, Seizeur R, Uro-Coste
E, Voirin J, Metellus P, Pallud J, Zemmoura I.
Natural
Course and Prognosis of Primary Spinal Glioblastoma: A Nationwide
Study.
Neurology.
2023 Jan 23:10.1212/WNL.0000000000206834∟.
doi: 10.1212/WNL.0000000000206834∟.
PMID: 36690453∟.
Observational study˰ ˍ
Berkman AM, Andersen CR,
Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson
SK, Milam J, Miller KA, Freyer DR, Roth ME.
Risk
of early death in adolescents and young adults with cancer: a
population-based study.
J
Natl Cancer Inst. 2023 Jan 23:djac206∟.
doi: 10.1093/jnci/djac206∟.
PMID: 36682385∟.
Observational study˰ ˍ
Giussani C, Carrabba G, Rui CB,
Chiarello G, Stefanoni G, Julita C, De Vito A, Cinalli MA, Basso
G, Remida P, Citerio G, Di Cristofori A.
Perilesional
resection technique of glioblastoma: intraoperative ultrasound and
histological findings of the resection borders in a single center
experience.
J
Neurooncol. 2023 Jan 23∟.
doi: 10.1007/s11060-022-04232-z∟.
PMID: 36690859∟.
Observational study. ˍ
Liu H, Zhang L, Tan Y, Jiang Y, Lu
H.
Observation
of the delineation of the target volume of radiotherapy in
adult-type diffuse gliomas after temozolomide-based
chemoradiotherapy: analysis of recurrence patterns and predictive
factors.
Radiat
Oncol. 2023 Jan 23;18(1):16∟.
doi: 10.1186/s13014-023-02203-w∟.
PMID: 36691100∟.
Observational study. ˍ
Liu R, Liu Q, Zhao K, Liu M, Sun G,
Xu B.
MR
Imaging, MGMT Promoter Methylation Features and Prognostic
Analysis of Subventricular Zone Contacting IDH Wild-type
Glioblastoma.
Curr
Med Imaging. 2023 Jan 23∟.
doi: 10.2174/1573405619666230123114753∟.
PMID: 36694322∟.
Observational study˰ ˍ
Li G, Yin C, Zhang C, Xue B, Yang
Z, Li Z, Pan Y, Hou Z, Hao S, Yu L, Ji N, Gao Z, Deng Z, Xie
J.
Spatial
distribution of supratentorial diffuse gliomas: A retrospective
study of 990 cases.
Front
Oncol. 2023 Jan 24;13:1098328∟.
doi: 10.3389/fonc.2023.1098328∟.
PMID: 36761940∟.
Observational
study. ˍ
Shen Q, Yang
H, Kong QP, Li GH, Li L.
Metabolic
Modeling Identifies a Novel Molecular Type of Glioblastoma
Associated with Good Prognosis.
Metabolites.
2023 Jan 24;13(2):172∟.
doi: 10.3390/metabo13020172∟.
PMID: 36837790∟.
Laboratory investigation. ˍ
Sidibe I,
Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, Ken
S, Noël G, Truc G, Sunyach M, Charissoux M, Magné N,
Lotterie JA, Roques M, Péran P, Cohen-Jonathan Moyal E,
Laprie A.
Pseudoprogression
versus true progression in patients with glioblastoma: A
multiapproach analysis.
Radiother
Oncol. 2023 Jan 24:109486∟.
doi: 10.1016/j.radonc.2023.109486∟.
PMID: 36706959∟.
Observational study˰ ˍ
Chiu D, Qi J, Thin TH, Garcia-Barros M, Lee B, Hahn M, Mandeli J,
Belani P, Nael K, Rashidipour O, Ghatan S, Hadjipanayis CG, Yong
RL, Germano IM, Brody R, Tsankova NM, Gnjatic S, Kim-Schulze S,
Hormigo A.
A Phase I Trial of VEGF-A
Inhibition Combined with PD-L1 Blockade for Recurrent
Glioblastoma.
Cancer
Res Commun. 2023 Jan 25;3(1):130-139∟.
doi: 10.1158/2767-9764.CRC-22-0420∟.
PMID: 36968223∟.
Interventional
study. ˍ
Coltin H,
Pequeno P, Liu N, Tsang DS, Gupta S, Taylor MD, Bouffet E, Nathan
PC, Ramaswamy V.
The
Burden of Surviving Childhood Medulloblastoma: A Population-Based,
Matched Cohort Study in Ontario, Canada.
J
Clin Oncol. 2023 Jan 25:JCO2202466∟.
doi: 10.1200/JCO.22.02466∟.
PMID: 36696605∟.
Observational study˰ ˍ
Czogała
M, Czogała W, Pawińska-Wąsikowska K, Książek
T, Bukowska-Strakova K, Sikorska-Fic B, Łaguna P,
Skalska-Sadowska J, Wachowiak J, Rodziewicz-Konarska A,
Moj-Hackemer M, Kałwak K, Muszyńska-Rosłan K,
Krawczuk-Rybak M, Fałkowska A, Drabko K, Kozłowska M,
Irga-Jaworska N, Bobeff K, Młynarski W, Tomaszewska R,
Szczepański T, Chodała-Grzywacz A, Karolczyk G, Mycko K,
Badowska W, Zielezińska K, Urasiński T, Bartoszewicz N,
Styczyński J, Balwierz W, Skoczeń S.
Pediatric
Acute Myeloid Leukemia Post Cytotoxic Therapy-Retrospective
Analysis of the Patients Treated in Poland from 2005 to
2022.
Cancers
(Basel). 2023 Jan 25;15(3):734∟.
doi: 10.3390/cancers15030734∟.
PMID: 36765692∟.
Observational study. ˍ
Nguyen TB,
Zakhari N, Velasco Sandoval S, Guarnizo-Capera A, Alexios Gulak M,
Woulfe J, Jansen G, Thornhill R, Majtenyi N, Cron GO.
Diagnostic
Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and
DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade
Gliomas: A Prospective Study.
AJNR
Am J Neuroradiol. 2023 Jan 26;44(2):134-142∟.
doi: 10.3174/ajnr.A7771∟.
PMID: 36702501∟.
Observational study˰ ˍ
Guo C, Yang Q, Xu P, Deng M, Jiang
T, Cai L, Li J, Sai K, Xi S, Ouyang H, Liu M, Li X, Li Z, Ni X,
Cao X, Li C, Wu S, Du X, Su J, Xue X, Wang Y, Li G, Qin Z, Yang H,
Zhou T, Liu J, Hu X, Wang J, Jiang X, Lin F, Zhang X, Ke C, Lv X,
Lv Y, Hu W, Zeng J, Chen Z, Zhong S, Wang H, Chen Y, Zhang J, Li
D, Mou Y, Chen Z.
Adjuvant
Temozolomide Chemotherapy With or Without Interferon Alfa Among
Patients With Newly Diagnosed High-grade Gliomas: A Randomized
Clinical Trial.
JAMA
Netw Open. 2023 Jan 27;6(1):e2253285∟.
doi: 10.1001/jamanetworkopen.2022.53285∟.
PMID: 36705923∟.
Interventional study. ˍ
da Costa MDS,
Sarti THM, Vaz H, Dastoli PA, Nicácio JM, Silva FAB,
Cappellano AM, Silva NS, Cavalheiro S.
Risk
for hydrocephalus, hygroma, and tumor dissemination after
ventricular opening during resection of supratentorial neoplasms
in children.
Childs
Nerv Syst. 2023 Jan 30∟.
doi: 10.1007/s00381-023-05861-z∟.
PMID: 36715744∟.
Observational study˰ ˍ
Beijer JGM,
Kok JL, Janssens GO, Streefkerk N, de Vries ACH, Slagter C, Maduro
JH, Kroon PS, Grootenhuis MA, van Dulmen-den Broeder E, Loonen JJ,
Wendling M, Tissing WJE, van der Pal HJ, Louwerens M, Bel A, den
Hartogh J, van der Heiden-van der Loo M, Kremer LCM, Teepen JC,
Ronckers CM.
Adverse
late health outcomes among children treated with 3D radiotherapy
techniques: Study design of the Dutch pediatric 3D-RT
study.
Cancer
Rep (Hoboken). 2023 Jan 30:e1620∟.
doi: 10.1002/cnr2.1620∟.
PMID: 36715495∟.
Observational study. ˍ
Marinelli A,
Cuomo M, Franca RA, Buonaiuto M, Costabile D, Pagano C, Trio F,
Montella L, Del Basso De Caro ML, Visconti R, Chiariotti L, Della
Monica R.
A
Rare Adult Primary Intracranial Sarcoma, DICER1-Mutant
Identified by Epigenomic Profiling: A Case Report.
Brain
Sci. 2023 Jan 30;13(2):235∟.
doi: 10.3390/brainsci13020235∟.
PMID: 36831778∟.
Case report. ˍ
°
Mendoza MG,
Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Adler JR,
Harraher C, Li G, Gephart MH, Nagpal S, Thomas RP, Recht LD,
Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von
Eyben R, Choi CYH, Soltys SG.
Patterns
of Progression in Patients with Newly Diagnosed Glioblastoma
Treated with 5 mm Margins on a Phase I/II Trial of 5 Fraction
Stereotactic Radiosurgery with Concurrent and Adjuvant
Temozolomide.
Pract
Radiat Oncol. 2023 Jan 30:S1879-8500(23)00035-8∟.
doi: 10.1016/j.prro.2023.01.008∟.
PMID: 36736621∟.
Interventional study˰ ˍ
Tonn S,
Korshunov A, Obrecht D, Sill M, Spohn M, von Hoff K, Milde T,
Pietsch T, Goschzik T, Bison B, Juhnke BO, Struve N, Sturm D, Sahm
F, Bockmayr M, Friedrich C, von Bueren AO, Gerber NU, Benesch M,
Jones DTW, Kool M, Wefers AK, Schüller U, Pfister SM,
Rutkowski S, Mynarek M.
Risk
prediction in early childhood SHH medulloblastoma treated with
radiation-avoiding chemotherapy: Evidence for more than two
subgroups.
Neuro
Oncol. 2023 Jan 30:noad027∟.
doi: 10.1093/neuonc/noad027∟.
PMID: 36715306∟.
Observational study˰ ˍ
Segar DJ,
Bernstock JD, Arnaout O, Bi WL, Friedman GK, Langer R, Traverso G,
Rampersad SM.
Modeling
of intracranial tumor treating fields for the treatment of complex
high-grade gliomas.
Sci
Rep. 2023 Jan 30;13(1):1636∟.
doi: 10.1038/s41598-023-28769-9∟.
PMID: 36717682∟.
Observational study. ˍ
Warnick
RE.
Treatment
of adverse radiation effects with Boswellia serrata after failure
of pentoxifylline and vitamin E: illustrative cases.
J
Neurosurg Case Lessons. 2023 Jan 30;5(5):CASE22488∟.
doi: 10.3171/CASE22488∟.
PMID: 36718863∟.
Case report. ˍ
Yu Z, Zhou Z,
Xu M, Song K, Shen J, Zhu W, Wei L, Xu H.
Prognostic
Factors of Gliosarcoma in the Real World: A Retrospective Cohort
Study.
Comput
Math Methods Med. 2023 Jan 30;2023:1553408∟.
doi: 10.1155/2023/1553408∟.
PMID: 36756387∟.
Observational study. ˍ
Zhang GT, Liu Q, Zuo FX, Liu HJ,
Wang SQ, Yuan Q, Liu AS, Hu K, Meng XL, Wang WJ, Qian HP, Wan JH,
Cai HQ.
Clinical
and genomic features in patients with second primary glioblastoma
following first primary renal cell carcinoma.
BMC
Cancer. 2023 Jan 30;23(1):104∟.
doi: 10.1186/s12885-023-10541-x∟.
PMID: 36717819∟.
Observational
study. ˍ
Broggi G,
Altieri R, Barresi V, Certo F, Barbagallo GMV, Zanelli M,
Palicelli A, Magro G, Caltabiano R.
Histologic
Definition of Enhancing Core and FLAIR Hyperintensity Region of
Glioblastoma, IDH-Wild Type: A Clinico-Pathologic Study on a
Single-Institution Series.
Brain
Sci. 2023 Jan 31;13(2):248∟.
doi: 10.3390/brainsci13020248∟.
PMID: 36831791∟.
Observational study. ˍ
Liu J, Li C,
Wang Y, Ji P, Guo S, Zhai Y, Wang N, Xu M, Wang J, Wang
L.
Prognostic
and predictive factors of secondary gliosarcoma: A
single-institution series of 18 cases combined with 89 cases from
literature.
Front
Oncol. 2023 Jan 31, 2022;12:1026747∟.
doi: 10.3389/fonc.2022.1026747∟.
PMID: 36798692∟.
Observational study. ˍ
Pöppe JP, Machegger L,
Steinbacher J, Stefanits H, Eisschiel S, Gruber A, Demetz M,
Ladisich B, Kraus TFJ, Weis S, Spiegl-Kreinecker S, Romagna A,
Griessenauer CJ, Jahromi BR, Rautalin I, Niemelä M, Korja M,
Schwartz C.
Surgeon
experience in glioblastoma surgery of the elderly-a multicenter,
retrospective cohort study.
J
Neurooncol. 2023 Jan 31∟.
doi: 10.1007/s11060-023-04252-3∟.
PMID: 36719614∟.
Observational
study. ˍ